Medical News

RSS

Lowering blood pressure below currently recommended targets reduces risk of stroke, heart attack

Using intensive treatment to lower blood pressure below currently recommended targets significantly reduces rates of major cardiovascular events like stroke and heart attack among a wide range of high-risk patients, according to a large meta-analysis involving almost 45000 individuals, published in The Lancet.

11 Nov 2015

Anavex reports safety and efficacy data of ANAVEX 2-73 Phase 2a trial in Alzheimer’s patients

On Saturday, investigators presented positive safety and cognitive efficacy data for ANAVEX 2-73, the Company’s lead investigational oral treatment for Alzheimer’s disease targeting sigma-1 and muscarinic receptors, which are believed to reduce protein misfolding including reduction of beta amyloid, tau protein and inflammation at the international CTAD 2015 conference in Barcelona, Spain.

11 Nov 2015

Adjunctive ultrasonography improves breast cancer detection

The addition of ultrasonography to mammography significantly improves the rate of detection of breast cancers in Japanese women, according to trial findings published in The Lancet.

10 Nov 2015

Mallinckrodt Study Shows Acthar® Reduces Disease Activity in Patients with Persistently Active Systemic Lupus Erythematosus

Data presented yesterday by researchers for Mallinckrodt plc, a leading specialty biopharmaceutical company, suggest that H.P. Acthar® Gel (repository corticotropin injection) reduces certain measures of disease activity in patients with persistently active Systemic Lupus Erythematosus (SLE) who are receiving corticosteroid therapy.

10 Nov 2015

Cotellic (cobimetinib) approved to be used in combination with vemurafenib for melanoma treatment

The U.S. Food and Drug Administration today approved Cotellic (cobimetinib) to be used in combination with vemurafenib to treat advanced melanoma that has spread to other parts of the body or can't be removed by surgery, and that has a certain type of abnormal gene (BRAF V600E or V600K mutation).

10 Nov 2015

Drinking one 16-ounce energy drink may increase risk of cardiovascular events in young adults

New research shows that drinking one 16-ounce energy drink can increase blood pressure and stress hormone responses significantly. This raises the concern that these response changes could increase the risk of cardiovascular events, according to a study presented today at the American Heart Association's Scientific Sessions 2015.

10 Nov 2015

White coat hypertension, masked hypertension increase cardiovascular events over the years

Patients whose blood pressures spikes in the doctor's office but not at home, and patients whose blood pressure spikes at home but not in the doctor's office, suffer more heart attacks, heart failure, and strokes than patients with normal blood pressures in both settings, UT Southwestern Medical Center researchers have found.

10 Nov 2015

Vitamin D deficiency puts people at risk of developing heart problems

A lack of vitamin D can result in weak bones. Recent studies also show that vitamin D deficiency is linked to more serious health risks such as coronary artery disease, heart attacks, and strokes.

10 Nov 2015

Research opens door for developing biomarker tests to detect cancers early

Biomarkers, which allow diseases to be diagnosed and staged based on relatively non-invasive blood tests, have been identified for several types of cancers, but for most cancers remain elusive. Now, research conducted at the RIKEN Center for Life Science Technologies in Japan and the Harry Perkins Institute of Medical Research in Australia has identified a large number of genes that are upregulated in many different types of cancer, opening the door for developing biomarker tests that could be used to detect cancers early, allowing for prompt treatment.

10 Nov 2015

Intensive management of high blood pressure reduces rates of cardiovascular disease, lowers risk of death

Jackson T. Wright Jr., MD, PhD, and researchers from University Hospitals Case Medical Center presented new results from the Systolic Blood Pressure Intervention Trial (SPRINT) showing that in patients at high risk for cardiovascular events, targeting a systolic blood pressure of less than 120 mm Hg resulted in lower rates of fatal and non-fatal major events or death compared to targeting systolic blood pressure to the usually recommended target of less than 140 mm Hg.

10 Nov 2015

New Global Energy and International Sustainability Group agree to manufacture, distribute MoringaUP Protein Bars

New Global Energy, Inc., a public company focused on Aqua-Farming, Agriculture, and Health & Wellness, has signed a distribution agreement with International Sustainability Group to manufacture and distribute MoringaUP Protein Bars based on ISG's popular AlgaeUp bars.

10 Nov 2015

Purple Button mobile app helps HMC achieve overall goal of improving patient safety, quality

CRG Medical officially announced today the implementation of the ONC for IT award winning Purple Button mobile patient safety application at HMC. The Purple Button, powered by CRG Medical, supports the KB Core High Reliability Patient Safety Evaluation System and has been instrumental in assisting HMC toward their overall goal of improving patient safety, quality and satisfaction.

10 Nov 2015

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

New Haven Pharmaceuticals, Inc. today announced new study data that shows the company's FDA-approved drug DURLAZA delivers sustained antiplatelet control for a full 24-hour period in high-risk patients.

10 Nov 2015

SKYGEN USA announces launch of Hylis Pharmacy Solutions

Citing a need to bring skyrocketing pharmacy costs under control, SKYGEN USA, the umbrella brand for a distinguished family of benefit management companies and technology solutions for health payers and healthcare organizations, today announced the launch of Hylis Pharmacy Solutions.

10 Nov 2015

Boston Children's and Rock Health team up to accelerate development of pediatric health technologies

Boston Children's Hospital and digital health venture fund Rock Health today announced a strategic partnership aimed at accelerating the development of pediatric health technologies. Detailed today during Boston Children's Hospital's Global Pediatric Innovation Summit + Awards (#PedInno15), the partnership will foster the development of digital tools and devices to improve pediatric care.

10 Nov 2015

Boston Scientific signs definitive agreement to acquire CeloNova's interventional radiology business

Boston Scientific has entered into a definitive agreement to acquire the interventional radiology portfolio of CeloNova Biosciences, a San Antonio-based developer of endovascular and interventional cardiology technologies.

10 Nov 2015

Perrigo receives FDA approval for generic version of KlorCon extended-release tablets

Perrigo Company plc today announced it has received an AB therapeutic equivalent rating and final U.S. Food and Drug Administration approval for the generic version of KlorCon extended-release tablets (600 mg and 750 mg), manufactured by Upsher-Smith Laboratories, Inc., and marketed by Sandoz Pharmaceuticals, Inc.

10 Nov 2015

Medical News

Lowering blood pressure below currently recommended targets reduces risk of stroke, heart attack

Anavex reports safety and efficacy data of ANAVEX 2-73 Phase 2a trial in Alzheimer’s patients

Adjunctive ultrasonography improves breast cancer detection

Mallinckrodt Study Shows Acthar® Reduces Disease Activity in Patients with Persistently Active Systemic Lupus Erythematosus

Cotellic (cobimetinib) approved to be used in combination with vemurafenib for melanoma treatment

Drinking one 16-ounce energy drink may increase risk of cardiovascular events in young adults

White coat hypertension, masked hypertension increase cardiovascular events over the years

Vitamin D deficiency puts people at risk of developing heart problems

Research opens door for developing biomarker tests to detect cancers early

Intensive management of high blood pressure reduces rates of cardiovascular disease, lowers risk of death

New Global Energy and International Sustainability Group agree to manufacture, distribute MoringaUP Protein Bars

Purple Button mobile app helps HMC achieve overall goal of improving patient safety, quality

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

SKYGEN USA announces launch of Hylis Pharmacy Solutions

Boston Children's and Rock Health team up to accelerate development of pediatric health technologies

Boston Scientific signs definitive agreement to acquire CeloNova's interventional radiology business

Perrigo receives FDA approval for generic version of KlorCon extended-release tablets

Inner ear damage brain warnings from nerve cells

Deep, uniform exome coverage in one day

VISERA 4K UHD endoscopy system gives surgeons 4x resolution

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News